Vesedaganat trials, also abroad
529 open Vesedaganat trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) has 2 sites in Szingapúr and runs in 24 countries. If a site near you is full, another one may still take people.
See A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) in all 24 countries